Targeted radiopharmaceuticals have become of widespread interest in the scientific community given their ability to detect and treat metastatic disease. We aim to validate the use of novel chelate-tethered eHSP-90 inhibitors as potential agents for detection...
Yiping He, Ph.D.
Radiopharmaceuticals, Theranostics, and Nuclear Medicine